Browse by People

Collapse authors list.
James, Nicholas D, Clarke, Noel W, Cook, Adrian, Ali, Adnan, Hoyle, Alex P, Attard, Gerhardt, Brawley, Christopher D, Chowdhury, Simon, Cross, William R, Dearnaley, David P et al (show 46 more authors) , de Bono, Johann S, Diaz-Montana, Carlos, Gilbert, Duncan, Gillessen, Silke, Gilson, Clare, Jones, Rob J ORCID: 0000-0001-5608-001X, Langley, Ruth E, Malik, Zafar I, Matheson, David J, Millman, Robin, Parker, Chris C, Pugh, Cheryl, Rush, Hannah, Russell, J Martin, Berthold, Dominik R, Buckner, Michelle L, Mason, Malcolm D, Ritchie, Alastair WS, Birtle, Alison J, Brock, Susannah J, Das, Prantik, Ford, Dan, Gale, Joanna, Grant, Warren, Gray, Emma K, Hoskin, Peter, Khan, Mohammad M, Manetta, Caroline, McPhail, Neil J, O'Sullivan, Joe M, Parikh, Omi, Perna, Carla, Pezaro, Carmel J, Protheroe, Andrew S, Robinson, Angus J, Rudman, Sarah M, Sheehan, Denise J, Srihari, Narayanan N, Syndikus, Isabel, Tanguay, Jacob S, Thomas, Carys W, Vengalil, Salil, Wagstaff, John, Wylie, James P, Parmar, Mahesh KB and Sydes, Matthew R (2022) Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476). INTERNATIONAL JOURNAL OF CANCER, 151 (3). pp. 422-434.

Collapse authors list.
Clarke, Caroline S, Hunter, Rachael M, Gabrio, Andrea, Brawley, Christopher D, Ingleby, Fiona C, Dearnaley, David P, Matheson, David, Attard, Gerhardt, Rush, Hannah L, Jones, Rob J ORCID: 0000-0001-5608-001X et al (show 12 more authors) , Cross, William, Parker, Chris, Russell, J Martin, Millman, Robin, Gillessen, Silke, Malik, Zafar, Lester, Jason F, Wylie, James, Clarke, Noel W, Parmar, Mahesh KB, Sydes, Matthew R and James, Nicholas D (2022) Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data. PloS one, 17 (6). e0269192-e0269192.